Oncology Drugs Market Size Is Developing Rapidly Worth $436.76 Billion By 2028
The global oncology drugs market size is expected to reach USD 436.76 billion by 2028, according to a new report by Million Insights. It is expected to expand at a CAGR of 12.0% from 2021 to 2028.
The global oncology drugs market size is expected to reach USD 436.76 billion by 2028, according to a new report by Million Insights. It is expected to expand at a CAGR of 12.0% from 2021 to 2028.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Oncology Drugs Market Size Is Developing
Rapidly Worth $436.76 Billion By 2028
“The global oncology drugs market size is expected to reach USD 436.76 billion by 2028.
It is expected to expand at a CAGR of 12.0% from 2021 to 2028. The market is expected
to witness growth due to the rising prevalence of cancer, availability of medical
resources for detecting and treating cancer patients, increasing pollution levels, and
changing lifestyles.
”
The global oncology drugs market size is expected to reach USD 436.76 billion by 2028. It is expected to expand at a
CAGR of 12.0% from 2021 to 2028. The market is expected to witness growth due to the rising prevalence of cancer,
availability of medical resources for detecting and treating cancer patients, increasing pollution levels, and changing
lifestyles. Additionally, the rising per capita income and the increasing purchasing power are other significant factors
driving the growth of the market.
The prostate segment is expected to register the second-fastest CAGR of 13.5% from 2021 to 2028. Prostate cancer is
the second leading cause of cancer-related deaths among men. Obesity and consumption of foods with high calcium
levels are some of the major factors leading to prostate cancer. Genetic mutation is also a major factor causing prostate
cancer. Growing awareness about the disease is contributing to various treatments and related drugs. Thus, the market
is expected to witness increasing revenue from prostate drugs during the forecast period.
North America held the largest revenue share of more than 40% in 2020. The U.S. is positively contributing to the
growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors
supporting the growth. North America is one of the promising regions to launch new technology in terms of well
healthcare infrastructure and advanced research and development activities that help innovate and produce the most
appropriate drugs to cure cancer. Additionally, ease of availability of drugs and reimbursement policies for the patients
in the healthcare industry are contributing to revenue generation.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/snapshots/oncology-drugs-market-report/request-demo
Oncology Drugs Market Report Highlights
• North America held the largest revenue share of more than 40% in 2020. The presence of well-established
pharmaceutical vendors is one of the key factors supporting the growth of the regional market
• The prostate segment is expected to register the second-fastest CAGR of 13.5% from 2021 to 2028. Growing
awareness about prostate cancer is contributing to various treatments and related drugs
• The breast segment is likely to expand at the highest CAGR of 13.8% from 2021 to 2028, due to the rising
prevalence and awareness regarding breast cancer
Oncology Drugs Market Segmentation
Million Insights has segmented the global oncology drugs market based on indication and region:
• Oncology Drugs Indication Outlook (Revenue, USD Million, 2017 - 2028)
• Lung
• Breast
• Colorectal
• Prostate
• Stomach
• Liver
• Others
• Oncology Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)
• North America
• U.S.
• Europe
• Germany
• France
• U.K.
• Asia Pacific
• China
• Japan
• Central & South America
• Brazil
• Middle East & Africa
• South Africa
List of Key Players of the Oncology Drugs Market
• Merck
• Novartis
• JOHNSON & JOHNSON
• Pfizer
• AstraZeneca
• Eli Lilly
• Hoffmann-La Roche
• AbbVie
• Sanofi
• GSK
Browse Full Research Report @
https://www.millioninsights.com/snapshots/oncology-drugs-market-report
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
410 E Santa Clara Street, Unit #1008 San Jose, CA 95113, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016
India
Phone: 91-8956380892